Samra Bachar, Yasmin Mohamad, Arnaout Sami, Azzi Jacques
Department of Internal Medicine, Staten Island University Hospital , NY, USA.
Hematol Rep. 2015 Sep 23;7(3):6100. doi: 10.4081/hr.2015.6100.
Hemophagocytic lymphohistiocytosis (HLH) is a rare and severe clinical syndrome characterized by a dysregulated hyperinflammatory immune response. The diagnosis of HLH during pregnancy is especially challenging due to the rarity of this condition. The highly variable clinical presentation, laboratory findings, and associated diagnoses accompanying this syndrome further complicate the problem. A pronounced hyperferritinemia in the setting of systemic signs and symptoms along with a negative infectious and rheumatological workup should raise suspicions for HLH. While treatment ideally consists of immunosuppressive chemotherapy and hematopoietic stem cell transplant, the potential toxicity to both the pregnant woman and the fetus poses a challenging decision. We report the first case of idiopathic HLH presenting as fever of unknown origin in a pregnant woman successfully treated with steroids.
噬血细胞性淋巴组织细胞增生症(HLH)是一种罕见且严重的临床综合征,其特征为免疫反应失调的过度炎症。由于该病症罕见,孕期HLH的诊断极具挑战性。该综合征高度可变的临床表现、实验室检查结果及相关诊断使问题更加复杂。在出现全身症状体征的情况下,显著的高铁蛋白血症以及感染和风湿病检查结果为阴性,应引起对HLH的怀疑。虽然理想的治疗方法是免疫抑制化疗和造血干细胞移植,但对孕妇和胎儿的潜在毒性带来了具有挑战性的决策。我们报告了首例表现为不明原因发热的特发性HLH孕妇,经类固醇治疗成功。